Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2022/10/046263
CTRI/2022/10/046263
Not yet recruiting
Phase 3

Comparative evaluation of Platelet Rich Plasma (PRP) versus Triamcinolone Acetonide and Hyaluronidase combination in the treatment of Oral Submucous Fibrosis.

Dr Ajay Kumar0 sites60 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: - Health Condition 2: R478- Other speech disturbances

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: - Health Condition 2: R478- Other speech disturbances
Sponsor
Dr Ajay Kumar
Enrollment
60
Status
Not yet recruiting
Last Updated
3 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
Dr Ajay Kumar

Eligibility Criteria

Inclusion Criteria

  • •1\. Patient above the age of 17 years to 65 years.
  • •2\. Patients clinically diagnosed with grade II and III OSMF patients (Clinical staging by Laiââ?¬•s, 1995\).
  • •3\. Patients who had not undergone any treatment for OSMF in the past 1 year.
  • •4\. Cooperative patients.
  • •5\. Patients without any systemic illness.
  • •6\. Patients who were willing to quit gutkha, arecanut and/or tobacco chewing habit.
  • •7\. Patients who agreed for regular follow ups.

Exclusion Criteria

  • •1\. OSMF patients with coexisting uncontrolled systemic illness.
  • •2\. Patients who had received previous treatment.
  • •3\. Patients with other mucosal/potentially medically disorders such as leukoplakia or lichen planus.
  • •4\. Patients with history of drug allergy.
  • •5\. Pregnant or breastfeeding women.
  • •6\. Patients not consenting to participate.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Phase 1
Comparison of two plasma derivates as pulpotomy agents in human immature molars
CTRI/2020/06/025938Terna Dental College
Not yet recruiting
Phase 4
Comparison of Platelet Rich Fibrin, Platelet Rich Plasma and mineral trioxide aggregate as pulpotomy agents in primary mandibular molars
CTRI/2024/06/068937DrAman Kumar
Recruiting
Phase 2
Comparing the effects of Platelet-rich plasma (PRP) with Corticosteroid injection in resistant tennis Elbow patients to non-surgical treatment
IRCT20191105045335N1Karaj University of Medical Sciences36
Recruiting
Phase 3
Comparison of the Platelet-rich plasma and hyaluronic acid injections in treatment of knee osteoarthritisOsteoarthritis.Polyosteoarthritis, unspecified
IRCT20180129038548N1Vice Chancellor for Research and Technology of Babol University of Medical Sciences81
Recruiting
Phase 2
The effectiveness of Combined Treatment of Carboxytherapy and Platelet-Rich Plasma (PRP) Compared to Platelet-Rich Plasma Alone, in the Treatment of Women with Androgenic Hair Loss Treated with Anti-Androgen Drugs.Women without Previous Underlying Disease, Suffering from Androgenic Hair Loss.Cicatricial alopecia [scarring hair loss]
IRCT20220919055994N2Kerman University of Medical Sciences20